Alnylam Pharmaceuticals, Inc. (ALNY) Posts Narrower than Expected Q1 Loss
Tweet
Share
E-mailGet Alerts ALNY Hot Sheet
Price: $247.91 -1.49%
EPS Growth %: -39.0%
Financial Fact:
Loss from operations: -92.45M
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: -39.0%
Financial Fact:
Loss from operations: -92.45M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) reported Q1 EPS of ($0.25), $0.11 better than the analyst estimate of ($0.36). Revenue for the quarter came in at $20.6 million versus the consensus estimate of $19.57 million.
For earnings history and earnings-related data on Alnylam Pharmaceuticals, Inc. (ALNY) click here.
For earnings history and earnings-related data on Alnylam Pharmaceuticals, Inc. (ALNY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paychex (PAYX) Tops Q1 EPS by 2c
- KB Home (KBH) PT Lowered to $50 at RBC Capital
- Scotiabank Reiterates Sector Outperform Rating on Ero Copper Corp. (ERO:CN) (ERO)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
